Cargando…
Update on Management of Cardiovascular Diseases in Women
Cardiovascular diseases (CVD) have a lower prevalence in women than men; although, a higher mortality rate and a poorer prognosis are more common in women. However, there is a misperception of CVD female risk since women have commonly been considered more protected so that the real threat is vastly...
Autores principales: | Lucà, Fabiana, Abrignani, Maurizio Giuseppe, Parrini, Iris, Di Fusco, Stefania Angela, Giubilato, Simona, Rao, Carmelo Massimiliano, Piccioni, Laura, Cipolletta, Laura, Passaretti, Bruno, Giallauria, Francesco, Leone, Angelo, Francese, Giuseppina Maura, Riccio, Carmine, Gelsomino, Sandro, Colivicchi, Furio, Gulizia, Michele Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911459/ https://www.ncbi.nlm.nih.gov/pubmed/35268267 http://dx.doi.org/10.3390/jcm11051176 |
Ejemplares similares
-
Management of Acute Coronary Syndrome in Cancer Patients: It’s High Time We Dealt with It
por: Lucà, Fabiana, et al.
Publicado: (2022) -
Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account
por: Lucà, Fabiana, et al.
Publicado: (2021) -
Reply to Kielb et al. Untapped Potential for Female Patients? Comment on “Lucà et al. Update on Management of Cardiovascular Diseases in Women. J. Clin. Med. 2022, 11, 1176”
por: Lucà, Fabiana, et al.
Publicado: (2022) -
The role of the pregnancy heart team in clinical practice
por: Lucà, Fabiana, et al.
Publicado: (2023) -
Superiority of Direct Oral Anticoagulants over Vitamin K Antagonists in Oncological Patients with Atrial Fibrillation: Analysis of Efficacy and Safety Outcomes
por: Parrini, Iris, et al.
Publicado: (2022)